CNW — CoDon AG Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €0.40m
- €5.41m
- €9.80m
Annual income statement for CoDon AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.33 | 5.65 | 6.86 | 6.23 | 9.8 |
Cost of Revenue | |||||
Gross Profit | 5.67 | 5.04 | 6.35 | 5.55 | 9.26 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.8 | 14.2 | 16.3 | 17.2 | 18.2 |
Operating Profit | -6.44 | -8.56 | -9.45 | -11 | -8.39 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.54 | -5 | -13.2 | -14.6 | -9.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.58 | -6.27 | -12.6 | -13.9 | -9.32 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.58 | -6.27 | -12.6 | -13.9 | -9.32 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.58 | -6.27 | -12.6 | -13.9 | -9.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.603 | -0.539 | -1.05 | -0.807 | -0.41 |
Dividends per Share |